TuHURA Biosciences Inc. (HURA)
NASDAQ: HURA
· Real-Time Price · USD
3.06
0.30 (10.87%)
At close: Aug 15, 2025, 3:59 PM
3.00
-2.12%
After-hours: Aug 15, 2025, 07:58 PM EDT
TuHURA Biosciences Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 17.64K | n/a | n/a | n/a | 15K | n/a | 15K | n/a | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 15K |
Gross Profit | -17.64K | n/a | n/a | n/a | -15K | n/a | -15K | n/a | -15K | -15K | -15K | -15K | -15K | -15K | -15K | -15K |
Operating Income | -5.69M | -2.21M | n/a | -4.61M | -1.02M | -4.56K | -3.35M | -18.74M | -3.5M | -4.65M | -5.46M | -5.36M | -5.89M | -5.97M | -6.7M | -6.61M |
Interest Income | 164.18K | n/a | n/a | 6.64K | 2K | n/a | 14K | 33.55K | 45K | 39K | 11K | 1K | 1K | 1K | 1K | 1K |
Pretax Income | -6M | -2.16M | n/a | -4.84M | -1.02M | -4.54K | -3.33M | -18.71M | -3.45M | -4.6M | -5.45M | -5.36M | -5.89M | -5.97M | -6.73M | -6.63M |
Net Income | -6M | -5.58K | n/a | -4.84M | -1.02M | -4.54K | -3.33M | -18.71M | -3.45M | -4.6M | -5.45M | -5.36M | -5.89M | -5.97M | -6.73M | -6.63M |
Selling & General & Admin | 1.7M | 1.96M | n/a | 1.02M | 893K | 1.1K | 1.26M | 924.2K | 1.43M | 1.46M | 1.44M | 1.87M | 1.98M | 2.16M | 2.65M | 2.75M |
Research & Development | 3.98M | 252K | n/a | 3.59M | 111K | 3.46K | 2.08M | 1.62M | 2.06M | 3.17M | 4M | 3.47M | 3.9M | 3.79M | 4.03M | 3.84M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 5.68M | 2.21M | n/a | 4.61M | 1M | 4.56K | 3.33M | 18.74M | 3.48M | 4.63M | 5.44M | 5.34M | 5.88M | 5.96M | 6.68M | 6.59M |
Interest Expense | 522.84K | n/a | n/a | 255.12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 27K | 30K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | -5.69M | 2.21M | n/a | 4.61M | -1.02M | 4.56K | -3.35M | 18.74M | -3.5M | -4.65M | -5.46M | -5.36M | -5.89M | -5.97M | -6.7M | -6.61M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 423.24K | 420.3K | 118.89K | 420.3K | 123.91K | 86.13K | 48.34K | 47.31K | 46.94K | 41.83K | 37.45K | 28.07K | 27.73K | 19.59K | 18.71K | 16.73K |
Shares Outstanding (Diluted) | 423.24K | 420.3K | 118.89K | 420.3K | 123.91K | 86.13K | 48.34K | 47.31K | 46.94K | 41.83K | 37.45K | 28.07K | 27.73K | 19.59K | 18.71K | 16.73K |
EPS (Basic) | -14.17 | -0.01 | -0.13 | -11.52 | -8.27 | -0.05 | -69.03 | -395.42 | -73.62 | -118.57 | -145.49 | -190.86 | -212.59 | -430.34 | -360.06 | -397.14 |
EPS (Diluted) | -14.17 | -0.01 | -0.13 | -11.52 | -8.27 | -0.05 | -69.03 | -395.42 | -73.62 | -118.57 | -145.49 | -190.86 | -212.59 | -430.34 | -360.06 | -397.14 |
EBITDA | -5.46M | -2.19M | n/a | -4.55M | -1.01M | -4.47K | -3.32M | -18.65M | -3.44M | -4.58M | -5.43M | -5.34M | -5.88M | -5.95M | -6.69M | -6.59M |
EBIT | -5.47M | -2.21M | n/a | -4.59M | -1.02M | -4.56K | -3.33M | -18.71M | -3.45M | -4.6M | -5.45M | -5.36M | -5.89M | -5.97M | -6.71M | -6.61M |
Depreciation & Amortization | 17.64K | 29K | n/a | 34.31K | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 15K | 15K |